Search Within

Elizabeth Siryeon Won

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
  3. Book Section (1)
Groups
  1. Department of Medicine (7)
  2. Gastrointestinal Oncology Service (7)
  3. Melanoma Disease Management Team (7)
  4. Melanoma and Immunotherapeutics Service (7)
  5. Solid Tumor Oncology Division (7)
  6. Survivorship Research (7)

More Groups

People
  1. Parisa Momtaz (7)
  2. David Ilson (4)
  3. David Kelsen (4)
  4. David Solit (4)
  5. Geoffrey Ku (4)
  6. Jaclyn Hechtman (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2014 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Nature (2)
  3. Annals of Oncology (1)
  4. Lancet Oncology (1)
  5. Pocket Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Nature Publishing Group (2)
  3. Elsevier Science, Inc. (1)
  4. Oxford University Press (1)
  5. Wolters Kluwer Health | Lippincott Williams & Wilkins (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Neurologic oncology
    Book Section

    Momtaz, P.; Kaley, T. J.; Won, E.; Batlevi, C. L.; Ryder, M.; Lacouture, M. E.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save